TVTX Earnings Travere Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q3 2026 | 2026-09-30 | -0.55 | 2026-11-02 | 10-Q |
| Q2 2026 | 2026-06-30 | -0.37 | 2026-08-04 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.40 | 2026-05-04 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 0.04 | 2026-02-19 | 10-K |
| FY 2025 | 2025-12-31 | -0.29 | 2026-02-19 | 10-K |
| Q3 2025 | 2025-09-30 | 0.28 | 2025-10-30 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.14 | 2025-08-06 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.47 | 2025-05-01 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -0.71 | 2025-02-21 | 10-K |
| FY 2024 | 2024-12-31 | -4.08 | 2025-02-21 | 10-K |
| Q3 2024 | 2024-09-30 | -0.70 | 2024-10-31 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.91 | 2024-08-01 | 10-Q |
| Q1 2024 | 2024-03-31 | -1.76 | 2024-05-06 | 10-Q |
| Q4 2023 | 2023-12-31 | -1.18 | 2024-02-20 | 10-K |
| FY 2023 | 2023-12-31 | -1.50 | 2024-02-20 | 10-K |
| Q3 2023 | 2023-09-30 | 1.97 | 2023-11-07 | 10-Q |
| Q2 2023 | 2023-06-30 | -1.13 | 2023-08-03 | 10-Q |
| Q1 2023 | 2023-03-31 | -1.27 | 2023-05-04 | 10-Q |
| Q4 2022 | 2022-12-31 | -1.03 | — | — |
| FY 2022 | 2022-12-31 | -4.37 | 2023-02-23 | 10-K |
| Q3 2022 | 2022-09-30 | -1.09 | 2022-10-27 | 10-Q |
| Q2 2022 | 2022-06-30 | -1.05 | 2022-08-04 | 10-Q |
| Q1 2022 | 2022-03-31 | -1.20 | 2022-05-05 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | -0.82 | 2022-02-24 | 10-K |
| FY 2021 | 2021-12-31 | -3.01 | 2022-02-24 | 10-K |
| Q3 2021 | 2021-09-30 | -0.59 | 2021-10-29 | 10-Q |
| Q2 2021 | 2021-06-30 | -0.64 | 2021-07-29 | 10-Q |
| Q1 2021 | 2021-03-31 | -0.96 | 2021-05-06 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | -2.56 | — | — |
| FY 2020 | 2020-12-31 | -3.56 | — | — |
| Q3 2020 | 2020-09-30 | -0.44 | — | — |
| Q2 2020 | 2020-06-30 | -0.58 | — | — |
| Q1 2020 | 2020-03-31 | 0.02 | 2020-05-11 | 10-Q |
| FY 2019 | 2019-12-31 | -3.46 | — | — |
| Q1 2019 | 2019-03-31 | -0.99 | — | — |
| Q4 2018 | 2018-12-31 | -0.18 | 2019-02-26 | 10-K |
| FY 2018 | 2018-12-31 | -2.54 | 2019-02-26 | 10-K |
| Q3 2018 | 2018-09-30 | -1.34 | — | — |
| Q2 2018 | 2018-06-30 | -0.56 | — | — |
| Q1 2018 | 2018-03-31 | -0.46 | 2018-05-01 | 10-Q |
| Q4 2017 | 2017-12-31 | -0.55 | 2018-02-27 | 10-K |
| FY 2017 | 2017-12-31 | -1.54 | 2018-02-27 | 10-K |
| Q3 2017 | 2017-09-30 | -0.46 | 2017-11-07 | 10-Q |
| Q2 2017 | 2017-06-30 | -0.34 | 2017-08-09 | 10-Q |
| Q1 2017 | 2017-03-31 | -0.32 | 2017-05-05 | 10-Q |
| Q4 2016 | 2016-12-31 | -0.39 | 2017-03-01 | 10-K |
| FY 2016 | 2016-12-31 | -1.29 | 2017-03-01 | 10-K |
| Q3 2016 | 2016-09-30 | -1.00 | 2016-11-04 | 10-Q |
| Q2 2016 | 2016-06-30 | -0.37 | 2016-08-05 | 10-Q |
| Q1 2016 | 2016-03-31 | -0.08 | 2016-05-05 | 10-Q |
| Q4 2015 | 2015-12-31 | -0.14 | 2016-02-26 | 10-K |
| FY 2015 | 2015-12-31 | 3.17 | 2016-02-26 | 10-K |
| Q3 2015 | 2015-09-30 | 1.78 | 2015-11-06 | 10-Q |
| Q2 2015 | 2015-06-30 | -0.73 | 2015-08-10 | 10-Q |
| Q1 2015 | 2015-03-31 | 1.32 | 2015-05-11 | 10-Q |
| Q4 2014 | 2014-12-31 | -1.10 | 2015-03-11 | 10-K |
| FY 2014 | 2014-12-31 | -4.43 | — | — |
| Q3 2014 | 2014-09-30 | -0.84 | 2014-11-13 | 10-Q |
| Q2 2014 | 2014-06-30 | -0.77 | 2014-08-14 | 10-Q |
| Q1 2014 | 2014-03-31 | -3.25 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.